This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
Reference
Borba HHL, et al. Effectiveness and Cost-Effectiveness of Triple Therapy with Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from the Brazilian Public Health System Perspective. Value in Health Regional Issues : 23 May 2019. Available from: URL: https://doi.org/10.1016/j.vhri.2019.02.005
Rights and permissions
About this article
Cite this article
Telaprevir more cost effective than boceprevir in triple therapy. PharmacoEcon Outcomes News 829, 28 (2019). https://doi.org/10.1007/s40274-019-5942-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5942-2